Risk of Disease Progression in Patients with Moderate Asymptomatic Carotid Artery Stenosis: Implications of Tobacco Use and Dual Antiplatelet Therapy
Hicks C, Talbott K, Canner J, Qazi U, Arhuidese I, Glebova N, Freischlag J, Perler B, Malas M. Risk of Disease Progression in Patients with Moderate Asymptomatic Carotid Artery Stenosis: Implications of Tobacco Use and Dual Antiplatelet Therapy. Annals Of Vascular Surgery 2014, 29: 1-8. PMID: 24530720, DOI: 10.1016/j.avsg.2014.02.007.Peer-Reviewed Original ResearchMeSH KeywordsAgedAngioplastyAsymptomatic DiseasesBaltimoreCarotid StenosisChi-Square DistributionDisease ProgressionDrug Therapy, CombinationEndarterectomy, CarotidFemaleHumansIncidenceIschemic Attack, TransientLinear ModelsMaleMultivariate AnalysisPlatelet Aggregation InhibitorsPredictive Value of TestsProportional Hazards ModelsRetrospective StudiesRisk FactorsSeverity of Illness IndexSmokingStentsStrokeTertiary Care CentersTime FactorsTreatment OutcomeUltrasonography, Doppler, DuplexConceptsProgression to severe stenosisAsymptomatic carotid artery stenosisDual antiplatelet therapyCarotid artery stenosisDisease progressionRisk factorsSevere stenosisIncidence of symptomsAntiplatelet therapyArtery stenosisPatient populationMean follow-up timeRisk of disease progressionSevere diseaseCox proportional hazards regression modelsRisk of progressionProportional hazards regression modelsFollow-up timeCarotid artery duplexAll-cause mortalityHazards regression modelsImproved medical therapyTransient ischemic attackTobacco useAsymptomatic carotid diseaseProgress toward elimination of malaria in Nigeria: Uptake of artemisinin-based combination therapies for the treatment of malaria in households in Benin City
Akoria O, Arhuidese I. Progress toward elimination of malaria in Nigeria: Uptake of artemisinin-based combination therapies for the treatment of malaria in households in Benin City. Annals Of African Medicine 2014, 13: 104-113. PMID: 24923369, DOI: 10.4103/1596-3519.134383.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAge DistributionAgedAnti-Infective AgentsAntimalarialsArtemisininsChildChild, PreschoolCross-Sectional StudiesDrug Therapy, CombinationFemaleHealth PolicyHumansInfantMalariaMaleMiddle AgedNational Health ProgramsNigeriaPlasmodiumRegression AnalysisSocioeconomic FactorsYoung AdultConceptsArtemisinin-based combination therapyRoll Back MalariaTreatment of malariaCombination therapyPatent medicine storesUptake of ACTsACT useNon-ACT antimalarialsFirst-line therapyElimination of malariaBenin CitySulfadoxine-pyrimethamineUncomplicated malariaArtemisinin monotherapyMalaria episodesMedicine storesGovernment hospitalsMalaria treatmentSocial Sciences versionAntimalarial medicinesMalariaPrivate hospitalsTherapySciences versionHospital